Presence of a p53 Gene Deletion in Patients With Multiple Myeloma Predicts for Short Survival After Conventional-Dose Chemotherapy
Johannes Drach(Vienna General Hospital), H. Huber(University Hospital Innsbruck), Maria DeSantis(University of Vienna), Heinz Ludwig(Wilhelminen Hospital), Heinz Gisslinger(University of Vienna), Elisabeth Krömer(University of Vienna), Niklas Zojer(University of Vienna), R. Roka(University of Vienna), E. Fritz(University of Vienna), Jutta Ackermann(University of Vienna), R. Heinz(University of Vienna), Michael Fiegl(University of Vienna), Rudolf Schuster(University of Vienna), J. C. Schuster(University of Vienna)
Cited by 321
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k